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Hospital based prospective observational case
study to evaluate the prevalance of diabetes
mellitus among tuberculosis patients in a
tertiary care hospital, in India
T.K. Charkha1,∗, S. Narreddy2
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2 Apollo Hospital, Hyderabad, India
Background: Diabetesmellitus (DM) is recognised as an impor-
tant risk factor to tuberculosis (TB). India has high TB burden, along
with rising DM prevalence. The recent change in life style of people
of India and westernization of food habits has contributed much to
make India the diabetes capital of world. Rapid urbanization has
resulted in crowding of cities and has led to rapid spread of infec-
tions. So inamajorly immunocompromised IndiabecauseofDM,TB
is a common infectious disease. Thus DM and TB affect each other.
In both the diseases the number of cases reported at tertiary care
centres is just the tip of iceberg. We conducted an observational
study at, Apollo Hospital, Hydearbad, India to look for prevalence
of TB among DM patients.
Methods & Materials: Patients older than 18 years with TB and
nototherwise immunocomprisedwereconsidered for the study.All
sputum positive, sputum negative and extra-pulmonary cases cur-
rently on anti-tuberculosis treatment and newly diagnosed were
included in the study that were admitted as inpatient or reported
as outpatient at Apollo Hospital in department of Medicine. TB
patientswere screened forDMthrough a thoroughhistory, detailed
examination and lab investigations.
Results: Seventyfour patients met the criteria and were
included in the study. In our study 24 of total 74 i.e.(32.43%) study
patients were found to be diabetic; mean agewas 46±17.8, (males
48.5±17.4 and females 44.3±19.5); 61% were male. Among the
diabetic population 80% were male (p value 0.0407). 11 of 24
DM patients were newly diagnosed which is 46% and 13 patients
(54%) were known diabetics. 35 patient (47%) were suffering from
pulmonary tuberculosis and 39 (53%) fromextra-pulmonary tuber-
culosis.
Conclusion: High prevalence of DM among TB patients was
found in or study at a tertiary care hospital in India. The prevalence
of DM was more in patients with pulmonary TB, among males and
patientswith history of smoking.We recommend screening for DM
among people with TB and vice versa, in a country like India with
a high double burden of disease.
http://dx.doi.org/10.1016/j.ijid.2016.02.836
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Role of PCR for diagnosing male genital
tuberculosis
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Background: Background: Diagnosis of male genital tuber-
culosis is difﬁcult because clinical features and imaging ﬁndings
are non-speciﬁc and conventional laboratory methods are time-
consuming andalmost non-contributory. It is important tohave the
diagnostic method that has high sensitivity and speciﬁcity. Hence,
this study was done to see the utility of tissue and semen PCR
in diagnosis of male genital tuberculosis and its comparison with
histopathological examination (HPE).
Methods & Materials: Methods and Materials: A prospec-
tive observational study was done from Jan 2006-Dec 2014 in
Department of Urology and Microbiology of Kasturba Medical Col-
lege, Manipal. 74 tissue samples (Epididymis 49, Prostate 20 and
Periurethtral 5) of suspected cases of male genital TB were pro-
cessed for both HPE and PCR. 15 semen samples from patients with
hematospermia were processed for only PCR.
Results: Results: 32 tissue samples (22 epididymis and 10
prostate tissues) were positive for both HPE and PCR whereas 36
samples were negative for both tests. False positive and false neg-
ativity was observed in 4(5.4%) and 2(2.7%) samples respectively.
Considering HPE as gold standard, PCR showed the sensitivity and
speciﬁcity as 88.9% and 94.7% respectively with kappa agreement
as 0.8. Time taken for PCR results was about 3.1 days as compare
to 6.2 days for HPE. Semen PCR showed positivity for 4 samples
(26.7%).
Conclusion: Conclusions: Tissue PCR is a sensitive and speciﬁc
method for obtaining early and timely diagnosis of male genital
tuberculosis. Semen PCR adds qualitative beneﬁt for diagnosing
tuberculosis in male genital tract.
http://dx.doi.org/10.1016/j.ijid.2016.02.837
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Intranasal delivery of antituberculosis agents in
a murine tuberculosis model
C. Shoen, M. Cynamon ∗
Veterans Affairs Medical Center, Syracuse, USA
Background: The use of aerosol delivery of antimycobacterial
agents for the therapy of tuberculosis in mice has not been well
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studied. Aerosol therapy in mice is problematic due to the high
cost of the required apparatus. The purpose of this study was to
explore the efﬁcacy of intranasal (IN) administration (as a surrogate
for aerosoldelivery)of isoniazid (INH)andrifalazil (RZL) inamurine
tuberculosis model compared to oral delivery.
Methods & Materials: Six week old female Balb/c mice (pur-
chased from Charles River Laboratories, Wilmington, MA) were
infected intranasally with about 103 CFU of Mycobacterium tuber-
culosis (MTB) ATCC 27294 (H37Rv) for experiment 1 or about 106
CFU ofMTBATCC 35801 (Erdman) for experiment 2. Oneweek post
infectionmice inexperiment1were treatedwith INH5mg/kgorally
by gavage or 5mg/kg IN for 3 days and mice in experiment 2 were
treated with RZL 5 mg/kg orally by gavage 5 days/week or 5 mg/kg
IN Mon, Wed, and Fri for 2 weeks. At the initiation of therapy in
each experiment a group of mice (early controls) were euthanized
by CO2 inhalation and their lungs were collected. At the comple-
tion of therapy an untreated group of mice, late controls (LC), and
treated mice were euthanized. Mycobacterial loads in right lungs
weremeasured by serial dilution and plating onMiddlebrook 7H10
agar plates.
Results: The mycobacterial loads (log CFU) for the EC, LC, INH
oral and INH IN were 3.34, 4.49, 2.94, and 2.82 respectively (exp.
1). The mycobacterial loads for the EC, LC, RZL oral, and RZL IN
were 6.26, 8.93, 4.30, and 4.58 respectively (exp. 2). The LC group
was euthanized 3 days early due to their advanced illness. IN deliv-
ery of INH and RIF was signiﬁcantly better than the untreated late
controls.
Conclusion: The activities of INH andRZL by INdelivery in these
experiments suggest that other agents that cannot be given orally
could be evaluated for their potential therapeutic activities by IN
administration.
http://dx.doi.org/10.1016/j.ijid.2016.02.838
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Real-time PCR of whole blood specimens
transported in PrimeStore MTM® to detect and
monitor MTB bacteremia
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Background:Mycobacterium tuberculosis (MTB) is an important
cause of bacteremia and sepsis in HIV patients residing in sub-
Saharan Africa.Many patientswithMTB sepsis go undiagnosed and
die within 18 days of presentation, making culture inadequate for
detecting MTB in the blood. Objective: To determine the feasibility
of ambient temperature transport of blood in PrimeStore MTM® to
a distant lab for real-time PCR detection of MTB bacteremia and to
monitor clearance of MTB from the blood after therapy.
Methods & Materials: BALB/c female mice were injected intra-
venously with 0.2 mls of ethanol killed MTB (approximately 105
CFU/mL). Two anti-MTB opsonophagocytic bactericidalMABswere
used to simulate treatment of MTB sepsis. Mouse monoclonal anti-
bodies (MAB LHN-AB9 or LHN-GG9) or control were given IP using
0.3 mls of sterile PBS 24 hours before MTB challenge. To monitor
MTB in the blood, mice were bled at 3 time points: immediately
after injection with MTB and again at 4 and 24 hours before MTB
challenge. Collected blood was placed into citrate tubes and 0.1ml
was transferred into PrimeStore MTM®. Samples were transported
at ambient temperature fromGaithersburg,MD to San Antonio, TX.
DNA was extracted from blood in PrimeStore MTM® and replicate
real-time polymerase chain reactions (PCR) were performed using
PrimeMix® MTB Complex on an ABI 7500 Instrument.
Results: Blood PCRs on specimens obtained 15 minutes after
MTBchallengewerepositivewithanaverageCT valueof29.8 (range
29.2-30.6). Mice treated with PBS control had MTB detected in the
blood by PCR at all time points (at 15 min, 4 and 24 hours post
challenge). Mice given anti-TB opsonic MABs cleared the MTB from
the blood either by 4 or 24 hours (CT =40).
Conclusion: Blood specimens were efﬁciently transported to
a central lab to detect MTB bacteremia by PCR. In addition, PCR
may be useful to monitor patient treatment, similar to viral load
testing for HIV. Using PrimeStore MTM® to ship specimens safely
and rapidly at ambient temperature to a regional facility for PCR
analysis may provide rural hospitals in sub-Saharan Africa the
opportunity to diagnose MTB sepsis and monitor treatment.
http://dx.doi.org/10.1016/j.ijid.2016.02.839
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GeneXpert detection of mycobacterium
tuberculosis from sputum collected and
transported in a molecular transport medium
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Background: The Cepheid GeneXpert (Xpert) System is a
WHO-endorsed, widely utilized molecular diagnostic platform for
Mycobacterium tuberculosis (MTB) and rifampin (RIF) detection.
In spite of global success, several challenges remain, especially the
need for safe, cost-effective transport/shipping, and improvedMTB
detection sensitivity. PrimeStore Molecular Transport Medium®
(PS-MTM) was developed for specimen inactivation and DNA/RNA
stabilization at ambient temperature for downstream molecular
applications. Aims: Xpert MTB-RIF assay was compared to real-
time PCR to evaluate detection of MTB and rifampin (RIF) in
PS-MTM or PBS control medium over a dynamic concentration
range. Furthermore, XpertMTB/RIF detectionwas performed using
clinical smear-positive sputum collected from swabs in PS-MTM
and PBS control, or processed as raw sputum.
